Universe Pharmaceuticals (UPC) Accounts Payables: 2021-2024
- Universe Pharmaceuticals' Accounts Payables rose 7.19% to $4.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $4.9 million, marking a year-over-year increase of 7.19%. This contributed to the annual value of $4.9 million for FY2024, which is 7.19% up from last year.
- According to the latest figures from Q3 2024, Universe Pharmaceuticals' Accounts Payables is $4.9 million, which was up 7.19% from $4.6 million recorded in Q3 2023.
- Over the past 5 years, Universe Pharmaceuticals' Accounts Payables peaked at $5.3 million during Q3 2021, and registered a low of $3.1 million during Q3 2022.
- Moreover, its 3-year median value for Accounts Payables was $4.6 million (2023), whereas its average is $4.2 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Accounts Payables crashed by 42.09% in 2022 and then surged by 49.10% in 2023.
- Universe Pharmaceuticals' Accounts Payables (Quarterly) stood at $5.3 million in 2021, then crashed by 42.09% to $3.1 million in 2022, then surged by 49.10% to $4.6 million in 2023, then climbed by 7.19% to $4.9 million in 2024.
- Its Accounts Payables was $4.9 million in Q3 2024, compared to $4.6 million in Q3 2023 and $3.1 million in Q3 2022.
